Literature DB >> 12436085

Applications of transcranial magnetic stimulation in movement disorders.

Roberto Cantello1.   

Abstract

The author reviews the applications of transcranial magnetic stimulation (TMS) in a series of movement disorders--namely, Parkinson's disease, corticobasal degeneration, multiple system atrophy, progressive supranuclear palsy, essential tremor, dystonia, Huntington's chorea, myoclonus, the ataxias, Tourette's syndrome, restless legs syndrome, Wilson's disease, Rett syndrome, and stiff-person syndrome. Single- and paired-pulse TMS studies have been done mainly for pathophysiologic purposes. Repetitive TMS has been used largely for therapy. Many TMS abnormalities are seen in the different diseases. They concur to show that motor cortical areas and their projections are the main target of the basal ganglia dysfunction typical of movement disorders. Interpretation has not always been clear, and sometimes there were discrepancies and contradictions. Largely, this may be the result of the extreme heterogeneity of the methods used and of the patients studied. It is premature to give repetitive TMS a role in treatment. Overall, however, TMS gives rise to a new, outstanding enthusiasm in the neurophysiology of movement disorders. There is reason to predict that TMS, with its continuous technical refinement, will prove even more helpful in the near future. Then, research achievements are reasonably expected to spill over into clinical practice.

Entities:  

Mesh:

Year:  2002        PMID: 12436085     DOI: 10.1097/00004691-200208000-00003

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  16 in total

1.  Cortical action myoclonus due to cortical laminar necrosis.

Authors:  Francesco Cavallieri; Valentina Fioravanti; Sara Contardi; Luca Codeluppi; Franco Valzania
Journal:  Neurol Sci       Date:  2013-09-20       Impact factor: 3.307

Review 2.  A practical guide to diagnostic transcranial magnetic stimulation: report of an IFCN committee.

Authors:  S Groppa; A Oliviero; A Eisen; A Quartarone; L G Cohen; V Mall; A Kaelin-Lang; T Mima; S Rossi; G W Thickbroom; P M Rossini; U Ziemann; J Valls-Solé; H R Siebner
Journal:  Clin Neurophysiol       Date:  2012-02-19       Impact factor: 3.708

3.  Utilizing transcranial magnetic stimulation to study the human neuromuscular system.

Authors:  David A Goss; Richard L Hoffman; Brian C Clark
Journal:  J Vis Exp       Date:  2012-01-20       Impact factor: 1.355

4.  Cortical excitability changes as a marker of cognitive impairment in Parkinson's disease.

Authors:  Nitish Kamble; Amitabh Bhattacharya; Shantala Hegde; N Vidya; Mohit Gothwal; Ravi Yadav; Pramod Kumar Pal
Journal:  Behav Brain Res       Date:  2022-01-05       Impact factor: 3.352

Review 5.  Treatment and physiology in Parkinson's disease and dystonia: using transcranial magnetic stimulation to uncover the mechanisms of action.

Authors:  Aparna Wagle Shukla; David E Vaillancourt
Journal:  Curr Neurol Neurosci Rep       Date:  2014-06       Impact factor: 5.081

6.  Motor cortex inhibition induced by acoustic stimulation.

Authors:  Andrea A Kühn; Andrew Sharott; Thomas Trottenberg; Andreas Kupsch; Peter Brown
Journal:  Exp Brain Res       Date:  2004-03-13       Impact factor: 1.972

7.  cSPider - Evaluation of a Free and Open-Source Automated Tool to Analyze Corticomotor Silent Period.

Authors:  Skadi Wilke; Dennis Groenveld; Ulrike Grittner; Jonathan List; Agnes Flöel
Journal:  PLoS One       Date:  2016-06-01       Impact factor: 3.240

8.  Muscles in "concert": study of primary motor cortex upper limb functional topography.

Authors:  Jean-Marc Melgari; Patrizio Pasqualetti; Flavia Pauri; Paolo Maria Rossini
Journal:  PLoS One       Date:  2008-08-27       Impact factor: 3.240

Review 9.  Modulation of cortical-subcortical networks in Parkinson's disease by applied field effects.

Authors:  Christopher W Hess
Journal:  Front Hum Neurosci       Date:  2013-09-13       Impact factor: 3.169

Review 10.  Transcranial magnetic stimulation to understand pathophysiology and as potential treatment for neurodegenerative diseases.

Authors:  Zhen Ni; Robert Chen
Journal:  Transl Neurodegener       Date:  2015-11-16       Impact factor: 8.014

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.